MedPath

Ultramicrosize Griseofulvin

ULTRAMICROSIZE GRISEOFULVIN TABLETS USP

Approved
Approval ID

efb8a660-802c-4ca6-bbff-ad7b48b91aef

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 5, 2023

Manufacturers
FDA

Chartwell RX, LLC.

DUNS: 079394054

Products 2

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Griseofulvin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code62135-495
Application NumberANDA061996
Product Classification
M
Marketing Category
C73584
G
Generic Name
Griseofulvin
Product Specifications
Route of AdministrationORAL
Effective DateOctober 5, 2023
FDA Product Classification

INGREDIENTS (6)

SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
GRISEOFULVINActive
Quantity: 250 mg in 1 1
Code: 32HRV3E3D5
Classification: ACTIB
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POLYETHYLENE GLYCOL 8000Inactive
Code: Q662QK8M3B
Classification: IACT

Griseofulvin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code62135-494
Application NumberANDA061996
Product Classification
M
Marketing Category
C73584
G
Generic Name
Griseofulvin
Product Specifications
Route of AdministrationORAL
Effective DateOctober 5, 2023
FDA Product Classification

INGREDIENTS (6)

STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
ANHYDROUS LACTOSEInactive
Code: 3SY5LH9PMK
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
POLYETHYLENE GLYCOL 8000Inactive
Code: Q662QK8M3B
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
GRISEOFULVINActive
Quantity: 125 mg in 1 1
Code: 32HRV3E3D5
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Ultramicrosize Griseofulvin - FDA Drug Approval Details